Leukemia - Chronic Lymphocytic - CLL


One of the patients of Dr. Filonov, Tatiana from Australia, shared her journey of recovery from Chronic Lymphocytic Leukemia🙏
She was diagnosed in 2020 and since than, no medical treatments have been done.
Her self-healing journey started with the 21-day water fast and, months later, she discovered Dr. Filonov. Since then, she went throught our 21-day online program https://healthyouniverse.online and have done several long-term dry fasts by herself.
Her persistent strong willpower and deep believe in the chosen method, after only 7 months of being with us, brought her to truly amazing results🙏
From the stage 4 of CHRONIC DISEASE she went to the stage when her Lymph nodes reduced in size. Blood tests have shown that her lymphocyte count has dropped by 35 percent and continues to slowly going down👌🏻
She is such an inspiring individual that we simply can not keep her amazing energy only for us🤗
We are happy to share this interview with Tatiana, and also, with her example, to give hope to those who are facing similar health problems.
It goes without saying that mental strength and determination to heal lead to true miracles🙏
Warm regards and enjoy the interview🤍
Dr. Filonov and Health YOUniverse team😊
#fasting #dryfastingresults #dryfastingbenefits #leukemie #leukemia #leukemiawarrior #leukemiasurvivor #leukemiaawareness #leukemiafighter


https://www.ossipinskyhealthacademy.com/
Visit our website to learn more about how to change your health and life!
John Ossipinksy explains how to help Help Chronic Lymphocytic Leukemia With Lymphatic System Detoxification to help reduce the buildup of cellular waste..


#Obinutuzumab is a humanized monoclonal antibody used as a combination treatment with chlorambucil to treat patients with untreated chronic lymphocytic leukemia. It was approved by the FDA in November 2013 and is marketed under the brand name Gazyva. There is a black box warning of fatal Hepatitis B Virus (HBV) reactivation and fatal Progressive Multifocal #Leukoencephalopathy (PML).
Obinutuzumab is an antineoplastic CD20 antibody used to treat untreated chronic lymphocytic leukemia in combination with chlorambucil.
Obinutuzumab is used as a combination treatment with chlorambucil to treat patients with untreated chronic lymphocytic leukemia.
#cancersucks #cancersurvivor #cancerseason #breastcancersurvivor #americancancersociety #cancersupport #cancers #cancersurvivors #breastcancersucks #kickcancersbutt #macmillancancersupport #breastcancersupport #cancersign #breastcancersurvivors #cancersux #kickingcancersbutt #kickingcancersass #ovariancancersurvivor #childhoodcancersucks #thyroidcancersurvivor #canadiancancersociety #cancersociety #cancerslayer #cancerslug #nationalcancersurvivorsday #irishcancersociety #cancersrock #cancerstinks #cancerszn #childhoodcancersurvivor #cancersticks #cancersun #cancersbelike #teamcancers #braincancer #coloncancersurvivor #caninecancer #pancreaticcancer #skincancer
Drug Today Medical Times (DTMT) is a leading medical and health news portal engaged in bridging the gap between the helathcare professionals and pharma industry for common man across India.
This bilingual channel is dedicated to bring news and views on health and medicine, catering to the health concious people in a form that is easily comprehensable for common man and health professionals at the same time
It not only serves the interest of the healthcare sector but also plays as a bulwark of medical industry safeguarding its core interests and guiding it in its service delivery.
We at Drug Today Medical Times are concious responsibities towards the society and tries to present news in an objective way without sensationalising the issue.
Please subscribe and share our channel for authentic, objective, health realed news
@DrugTodayMedicalTimes
We are also on #facebbok & #instagram
To follow us:
Instagram: https://www.instagram.com/drugtodaymedicaltimes
Facebook: https://www.facebook.com/drugtodaymedicaltimes
Twitter: https://twitter.com/DTMedicalTimes


Carl June is the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine. He is currently Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine, and Director of the Parker Institute for Cancer Immunotherapy at the University of Pennsylvania. He is a graduate of the Naval Academy in Annapolis, and Baylor College of Medicine in Houston, 1979. He had graduate training in Immunology and malaria with Dr. Paul-Henri Lambert at the World Health Organization, Geneva, Switzerland from 1978-79, and post-doctoral training in transplantation biology with E. Donnell Thomas and John Hansen at the Fred Hutchinson Cancer Research Center in Seattle from 1983 - 1986. He is board certified in Internal Medicine and Medical Oncology. He maintains a research laboratory that studies various mechanisms of lymphocyte activation that relate to immune tolerance and adoptive immunotherapy for cancer and chronic infection. In 2011, his research team published findings detailing a new therapy in which patients with refractory and relapsed chronic lymphocytic leukemia were treated with genetically engineered versions of their own T cells. The treatment has also now also been used with promising results to treat children with refractory acute lymphoblastic leukemia. He has published more than 350 manuscripts and is the recipient of numerous prizes and honors, including election to the Institute of Medicine in 2012 and the American Academy of Arts and Sciences in 2014, the William B Coley award, the Richard V Smalley Memorial Award from the Society for Immunotherapy of Cancer, the AACR-CRI Lloyd J. Old Award in Cancer Immunology, the Philadelphia Award in 2012, the Taubman Prize for Excellence in Translational Medical Science in 2014 (shared w S. Grupp, B. Levine, D. Porter), the Paul Ehrlich and Ludwig Darmstaedter Prize (shared w J. Allison), the Novartis Prize in Immunology (shared w Z. Eshaar and S. Rosenberg), the Karl Landsteiner Memorial award, the Debrecen Award and a lifetime achievement award from the Leukemia and Lymphoma Society.
https://en.wikipedia.org/wiki/Carl_H._June
#biotechnology #science #vc #startup #startups #startupideas #biology #biotech #chemistry #business #speech #speeches #investing #investment #lifescience #casestudy #scientist #scientists #inventors #inventor #inventions #invention #research #innovation #siliconvalley #entrepreneur #entrepreneurship #entrepreneurs #healthcare #genomics #genetics #history #biologia #technology #tech #founderstories #founder #founders #founderstory #scienceandtechnology #sciencestory #stories #bioengineering #engineering #engineer #biochemistry #discovery #discover #technical #health #education #educational #learning #learn #podcast #podcasts #podcasting #podcaster #technews
Axial Newsletter: https://axial.substack.com/
Build with Axial: https://build.axialvc.com/
https://linktr.ee/axialxyz


leukemia symptoms || treatment for chronic lymphocytic leukemia || chronic lymphocytic leukemia.
For more information about health click on website url http://www.care8healthtips.com/
If you see these symptoms, understand what leukemia is. You know that leukemia is also known as blood cancer. That is, leukemia affects the process of blood becoming too much. Symptoms of leukemia are similar to those of cancer, but do you know there are certain symptoms of recognizing leukemia. But the question arises that the symptoms of leukemia are identified through diagnosis, or leukemia can be commonly recognized. After all, what are the symptoms that make it easier to identify leukemia. At the same time, the question arises as to what should be done if the symptoms of leukemia come into being. Is there any cure for leukemia cancer? To know the answers to all the questions we must first know the symptoms of leukemia. So let's know what the symptoms of leukemia are.
• You know that leukemia's symptoms are like cancer. That is, the cells of cancer that prevent other parts of the body from functioning efficiently.
• Leukemia cells are usually spreading in blood cells and various parts of the body, but some leukemia cells spread very rapidly in the body.
Symptoms of leukemia
Frequent infection of the same type
• High fever.
• Impaired patient's immune system
• Feeling of fatigue and weakness at all times.
• Anemia
• Complaining of bleeding from the nose and gums etc.
• Fall of platelets.
• Pain in the joints of the body. "
• Complaints of bone pain
• Swelling in different parts of the body.
• Feeling of being in the place of bumps in the body
Having lever related problems
• Frequent complaints of headache Or to be a migraine complain
• Stroke, ie stroke.
• Frequent confusion of having a trail or something That is, many times the patient seems mentally disturbed.
• feeling vomiting, or having vomiting.
• Complain of rhesus in place of skin
• Swelling of glands / glands
• Sudden abnormal weight loss without reason.
• Swelling of the jaws or the bleeding of the blood.
• Having no appetite problem
• If injury has occurred, then the injury marks.
• It takes more time to fill any wound or wound.
Although early symptoms of leukemia are flu and many other serious diseases, but when leukemia begins to grow then all the above-mentioned problems start to occur. Sometimes these problems are ignored if leukemia cancer cells, i.e. these tumor cells spread to other parts of the body. By which the body starts to appear abnormally swollen and the body seems to be very crappy. If you can identify the symptoms of leukemia at the right time and get treatment, then you can get out of the risk of leukemia.